Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to investigate the effect of UGT1A1 inhibition by single and multiple oral doses of BI
201335 on the single and multiple oral dose pharmacokinetics of raltegravir and to
investigate safety and tolerability.